Levonorgestrel Intrauterine System For Emergency Contraception
NCT01539720 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 274
Last updated 2024-02-20
Summary
The purpose of this research study is to test the levonorgestrel intrauterine system as a method for emergency contraception. Emergency contraception refers to pregnancy prevention after an act of intercourse.
While the levonorgestrel intrauterine system is approved as a contraceptive method, it is considered investigational as emergency contraception, which means that it has not been approved by the U.S. Food and Drug Administration. This study will compare the device to the most common types of emergency contraception, oral Ulipristal acetate, or oral levonorgestrel. The oral levonorgestrel regimen was approved as a method of emergency contraception by the U.S. Food and Drug Administration in 1998. This method involves taking a 1.5mg pill of levonorgestrel in a single, one time dose. The Ulipristal acetate was approved as a method of emergency contraception by the U.S. Food and Drug Administration in 2010. This method involves taking a 30mg pill of Ulipristal acetate in a single, one time dose.
Conditions
- Pregnancy, Unplanned
- Pregnancy; Accident
Interventions
- DRUG
-
Ulipristal acetate
30 mg tablet
- DEVICE
-
levonorgestrel IUS
Levonorgestrel IUS, 52mg placed intrauterine
Sponsors & Collaborators
-
William and Flora Hewlett Foundation
collaborator OTHER -
University of Colorado, Denver
collaborator OTHER -
Planned Parenthood Federation of America
collaborator OTHER -
University of Rochester
collaborator OTHER -
Planned Parenthood of the St. Louis Region and Southwest Missouri
lead OTHER
Principal Investigators
-
Colleen McNicholas, DO, MCSI · Planned Parenthood of the St. Louis Region and Southwest Missouri
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 14 Years
- Max Age
- 45 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2012-12-31
- Primary Completion
- 2018-11-30
- Completion
- 2018-11-30
Countries
- United States
Study Locations
More Related Trials
-
Impact of Combined Hormonal Contraceptives on UPA
NCT02577601 ·Status: COMPLETED ·Phase: PHASE4
-
Study of a Levonorgestrel 52 mg Intrauterine System for the Treatment of Heavy Menstrual Bleeding
NCT03642210 ·Status: COMPLETED ·Phase: PHASE3
-
Levonorgestrel-piroxicam Versus Ulipristal Acetate for Emergency Contraception
NCT06727734 ·Status: RECRUITING ·Phase: PHASE3
-
Efficacy Trial of CDB 2914 for Emergency Contraception
NCT00271583 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Emergency Contraception and Body Weight: Pilot Study
NCT02408692 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of a Levonorgestrel-Releasing Intrauterine System for Long-Term, Reversible Contraception
NCT00995150 ·Status: TERMINATED ·Phase: PHASE3
-
Same Day Oral EC and Implant Initiation
NCT04678817 ·Status: COMPLETED
-
Levonorgestrel-Intrauterine System (LNG-IUS) Insertion in the Postpartum Period
NCT01088178 ·Status: WITHDRAWN ·Phase: NA
-
Stopping Heavy Periods Project
NCT02002260 ·Status: UNKNOWN ·Phase: NA
-
Immediate Versus Delayed Initiation of Intrauterine System
NCT03708809 ·Status: WITHDRAWN ·Phase: NA
-
Advance Supply of Emergency Contraception Compared to Routine Postpartum Care in Teens
NCT00433004 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Efficacy of CDB-2914 for Emergency Contraception
NCT00411684 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of CDB-2914 in Comparison to Levonorgestrel for Emergency Contraception
NCT00551616 ·Status: COMPLETED ·Phase: PHASE3
-
Pretreatment With Norethindrone Acetate Prior to Levonorgestrel IUS Insertion for Heavy Menstrual Bleeding
NCT01391052 ·Status: UNKNOWN ·Phase: PHASE4
-
Safety and Expulsion of Delayed Versus Immediate Postpartum Intrauterine Device Placement
NCT01598662 ·Status: TERMINATED ·Phase: NA
-
A Study of the Drug Interactions Between a Hormonal Emergency Contraception and an HIV Medication
NCT00482963 ·Status: COMPLETED ·Phase: PHASE1
-
Same-day Long-acting Reversible Contraception for Medication Abortion
NCT01356927 ·Status: COMPLETED
-
Pericoital Oral Contraception With Levonorgestrel
NCT00922233 ·Status: COMPLETED ·Phase: PHASE3
-
Intervention to End Recurrent Unscheduled Bleeding Trial
NCT03118297 ·Status: COMPLETED ·Phase: PHASE3
-
Drospirenone-only Pill as Emergency Contraception
NCT05675644 ·Status: UNKNOWN ·Phase: PHASE2
-
Study Evaluating Levonorgestrel and Ethinyl Estradiol for Oral Contraception
NCT00245921 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of the Efficacy and Safety of LevoCept
NCT02882191 ·Status: COMPLETED ·Phase: PHASE2
-
Prevention of Ovulation Achieved by Single Intra-vaginal Administration of Levogel as Compared to Oral LNG
NCT01286948 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase I Study to Evaluate the PK and PD of a Single Injection of Levonorgestrel Butanoate for Female Contraception
NCT02173808 ·Status: COMPLETED ·Phase: PHASE1
-
Study Evaluating Levonorgestrel and Ethinyl Estradiol for Oral Contraception
NCT02021097 ·Status: UNKNOWN ·Phase: PHASE3